LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients

被引:7
|
作者
Chang, Yue [1 ,2 ]
He, Jiange [1 ]
Xiang, Xiaohui [2 ]
Li, Hai [2 ]
机构
[1] Logist Univ Peoples Armed Ploce Force, Grad Sch, Tianjin 300162, Peoples R China
[2] Tianjin Xiqing Hosp, Div Gastroenterol & Hepatol, 403 Xiqing Rd, Tianjin 300380, Peoples R China
关键词
Nonalcoholic fatty liver disease; Gene; Coexpression network; Pathway; LUM;
D O I
10.1016/j.clinre.2020.04.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction. - Advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is associated with a poor prognosis. The genetic factors contributing to fibrosis in NAFLD have been described. However, the genetic mechanism and hub genes of advanced fibrosis have not been elucidated to date. In this study, we performed a weighted gene coexpression network analysis (WGCNA) to identify the hub genes related to advanced fibrosis in NAFLD. Materials and methods. - The datasets GSE89632 and GSE31803 of NAFLD patients were selected from the Gene Expression Omnibus (GEO) database of NCBI and analyzed by WGCNA. The hub genes were selected in the GSE31803 dataset and verified in the GSE31803 dataset. Gene Ontology (GO) term enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the dataset were also performed. Results. - The gene LUM was identified as the hub gene in the datasets GSE89632 and GSE31803 according to three different algorithms (gene significance and module membership, the pathways of the genes, and protein expressed by the genes). The functional enrichment analysis shows that the identified module is related to the extracellular matrix, regulation of cell proliferation, and the inflammatory response. The metabolic pathway analysis identified metabolic pathways and focal adhesion as the most important pathways. Conclusion. - By a variety of methods, LUM was identified as the hub gene of advanced fibrosis in patients with NAFLD. Therefore, further research on the LUM gene is warranted. (c) 2020 L'Auteur(s). Publi ' e par Elsevier Masson SAS. Cet article est publi ' e en Open Access sous licence CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease
    Bril, Fernando
    Pearce, Ryan W.
    Collier, Timothy S.
    McPhaul, Michael J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, : 42 - 51
  • [32] Accuracy of noninvasive scoring systems to assess advanced liver fibrosis in Thai patients with nonalcoholic fatty liver disease
    Treeprasertsuk, Sombat
    Piyachaturawat, Panida
    Soontornmanokul, Tanassanee
    Wisedopas-Klaikaew, Naruemon
    Komolmit, Piyawat
    Tangkijavanich, Pisit
    ASIAN BIOMEDICINE, 2016, 10 : S49 - S55
  • [33] Clinical Implications of Cardiac Symptoms and Electrocardiographic Abnormalities for Advanced Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
    Kang, Min-Kyu
    Kim, Min-Cheol
    MEDICINA-LITHUANIA, 2023, 59 (02):
  • [34] Are low triglyceride levels the cause or an outcome of advanced liver fibrosis in elderly patients with nonalcoholic fatty liver disease?
    Kogiso, Tomomi
    Hashimoto, Etsuko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) : 1459 - 1460
  • [35] Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
    Aggarwal, Manik
    Garg, Rajat
    Parthasarthy, Gopanandan
    Nowacki, Amy S.
    Padival, Ruthvik
    McCullough, Arthur
    Qazi, Taha
    Click, Benjamin
    Rieder, Florian
    Cohen, Benjamin L.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (03) : 1006 - 1015
  • [36] Crohn’s Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
    Manik Aggarwal
    Rajat Garg
    Gopanandan Parthasarthy
    Amy S. Nowacki
    Ruthvik Padival
    Arthur McCullough
    Taha Qazi
    Benjamin Click
    Florian Rieder
    Benjamin L. Cohen
    Digestive Diseases and Sciences, 2023, 68 : 1006 - 1015
  • [37] Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
    Moylan, Cynthia A.
    Abdelmalek, Manal F.
    HEPATOLOGY, 2018, 68 (04) : 1646 - 1648
  • [38] Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
    Caussy, Cyrielle
    Soni, Meera
    Cui, Jeffrey
    Bettencourt, Ricki
    Schork, Nicholas
    Chen, Chi-Hua
    Al Ikhwan, Mahdi
    Bassirian, Shirin
    Cepin, Sandra
    Gonzalez, Monica P.
    Mendler, Michel
    Kono, Yuko
    Vodkin, Irine
    Mekeel, Kristin
    Haldorson, Jeffrey
    Hemming, Alan
    Andrews, Barbara
    Salotti, Joanie
    Richards, Lisa
    Brenner, David A.
    Sirlin, Claude B.
    Loomba, Rohit
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (07): : 2697 - 2704
  • [39] THE EFFECT OF MICROVASCULAR COMPLICATIONS OF DIABETES ON ADVANCED FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE
    Rosenblatt, Russell E.
    Buckholz, Adam
    Ghosh, Gaurav
    Sherman, Zachary
    Lucero, Catherine
    Jesudian, Arun
    Fortune, Brett
    Kumar, Sonal
    GASTROENTEROLOGY, 2018, 154 (06) : S1165 - S1165
  • [40] Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis
    Chen, Hao-Kai
    Luo, Jing
    Li, Xiu-Juan
    Liao, Wan-Zhe
    Hu, Yu-Qi
    Guo, Xu-Guang
    SCIENTIFIC REPORTS, 2023, 13 (01):